Navigation Links
Concord Medical to Report Second Quarter 2014 Financial Results on August 13, 2014
Date:8/5/2014

BEIJING, Aug. 5, 2014 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical", or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced it will release its financial results for the second quarter of 2014 after the market closes on August 13, 2014.

Management will hold a conference call to discuss the results the following day, at 8:00 a.m. Eastern Time on August 14, 2014 (8:00 p.m. in Beijing/Hong Kong on August 14, 2014).

The dial-in details for the live conference call are as follows:U.S. Toll Free: 

1 866 519 4004International: 

65 67239381U.K. Toll Free: 

08082346646Hong Kong Toll Free: 

800-930-346China Local: 

400-620-8038 / 800-819-0121Passcode: 

CCMA replay of the conference call may be accessed by phone at the following numbers for 7 days:

U.S. Toll Free: 

1 855 452 5696International: 

6 12 8199 0299Conference ID:

84718519Additionally, a live and archived webcast of the conference call will be available on the investor relations section of the Company's website at: http://ir.concordmedical.com/

About Concord MedicalConcord Medical Services Holdings Limited operates the largest network of radiotherapy and diagnostic imaging centers in China, measured by revenues and the number of centers in operation and is the parent of Chang'an Hospital. As of March 31, 2014, the Company operated a network of 140 centers with 80 hospital partners that spanned 55 cities and 25 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in China, Concord Medical provides radiotherapy and diagnostic imaging equipment and manages the daily operations of these centers, which are located on the premises of its hospital partners. The Company also provides ongoing training to doctors and other medical professionals in its network of centers to ensure a high level of clinical care for patients. For more information, please see http://ir.concordmedical.com.

For more information, please contact:

Mr. Adam J. Sun (Chinese and English)
+86 10 5957 5266
adam.sun@concordmedical.com

Mr. Ting Jia (Chinese and English)
+86 10 5957 5270
ting.jia@concordmedical.com

Ms. Fang Liu (Chinese and English)
+86 10 5903 6688 (ext. 639)
fang.liu@concordmedical.com

ICR Inc.

In China:
Ms. Rene Jiang
+86-10-6583-7521
rene.jiang@icrinc.com

In the United States:
Mr. William Zima
+1-203-682-8233
William.Zima@icrinc.com


'/>"/>
SOURCE Concord Medical Services Holdings Limited
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Concord Medical Declares Special Dividend
2. Concordia Healthcare Corp. announces FDA agreement on Special Protocol Assessment for Phase 3 Clinical trial on new therapy to treat perihilar cholangiocarcinoma
3. Concord Medical Declares Special Dividend
4. Concord Medical Announces Results of 2013 Annual General Meeting; Appoints New Board Members
5. Concord Medical Announces the Closing of Acquisition of Its Shares by CEO and COO from Other Shareholders
6. Concord Medical Signs MOU with Shanghai New Hongqiao International Medical Center and GE Healthcare to Establish a Medical Imaging Diagnosis Center
7. Concord Medical Reports Third Quarter 2013 Financial Results and Reiterates Financial Year Guidance Forecast
8. Concord Medical to Report Third Quarter 2013 Financial Results on November 12, 2013
9. Concord Medical Announces Acquisition of Its Shares by CEO and COO from Other Shareholders
10. Concord Medical Reports Second Quarter 2013 Financial Results
11. Concord Medical to Report Second Quarter 2013 Financial Results on Aug 12, 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Japan , Dec. 9, 2016 Mitsubishi ... ; President & Representative Director, CEO: Dr. Masayuki ... amyotrophic lateral sclerosis (ALS) given edaravone intravenously in 10-14 ... loss as measured by the ALS Functional Rating Scale-Revised ... International Symposium on ALS/MND in Dublin, ...
(Date:12/9/2016)... Research and Markets has announced the addition of the ... ... travel vaccines market to grow at a CAGR of 6.83% during ... and the growth prospects of the global travel vaccines market for ... generated from the sales of various vaccines administered to actively immunize ...
(Date:12/9/2016)... DIEGO , Dec. 9, 2016  Forge ... Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: ... targeting ,LpxC, for the treatment of bacterial infections ... has been recognized as an attractive antibacterial target ... a lack of suitable chemical starting points has ...
Breaking Medicine Technology:
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Chester County, a Property owned by an affiliate of Seavest, has won a ... Penn Medicine Southern Chester County ambulatory care center (ACC) was named “Best New ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman ... law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at ... DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical Technology Group ...
(Date:12/8/2016)... Somerset, N.J. (PRWEB) , ... December 08, 2016 ... ... advanced delivery technologies and development solutions for drugs, biologics and consumer health products, ... The PSCI was set up in 2006 as a non-profit organization to unite ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... surgery as possible. With this in mind, SIGVARIS has created a new line ... clot) during bed rest and provide the benefits of graduated compression when transitioning ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Dianne Michael Insurance ... in Hamilton County, is embarking on a charity drive with the aim of ... homes for orphaned or neglected senior dogs in the Cincinnati region, and LuvFurMutts ...
Breaking Medicine News(10 mins):